Development of Pyrazole Compounds as Antidiabetic Agent: A Review

E-ISSN： 1875-628x|11|5|686-703

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.11, Iss.5, 2014-06, pp. : 686-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Thiadiazole as an Antidiabetic Agent- A Review

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 2, 2014-02 ,pp. : 136-153

Bentham Science Publishers

Access to resources Recommend Favorite

Are Vanadium Compounds Drugable? Structures and Effects of Antidiabetic Vanadium Compounds: A Critical Review

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-11 ,pp. : 995-1008

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1

By Parkes David G Mace Kenneth F Trautmann Michael E

Expert Opinion on Drug Discovery, Vol. 8, Iss. 2, 2013-02 ,pp. : 219-244

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative

By Shibata T. Matsui K. Nagao K. Shinkai H. Yonemori F. Wakitani K.

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 211-219

Elsevier

Access to resources Recommend Favorite

Identification of Pyrazole Derivative as an Antiviral Agent Against Chikungunya Through HTVS

Letters in Drug Design & Discovery, Vol. 12, Iss. 4, 2015-05 ,pp. : 292-301

Bentham Science Publishers

Access to resources Recommend Favorite